The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL)

Recently, the ratio of C-reactive protein to albumin (CAR) is used as an inflammatory marker that has been demonstrated to be a simple and reliable prognostic factor in solid tumors and hematological malignancy. However, no studies of the CAR have been performed in patients with adult T-cell leukemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawano, Noriaki, Shimonodan, Hidemi, Nagahiro, Yuri, Yoshida, Shuro, Kuriyama, Takuro, Takigawa, Ken, Tochigi, Taro, Nakaike, Takashi, Makino, Shigeyoshi, Yamashita, Kiyoshi, Marutsuka, Kousuke, Ochiai, Hidenobu, Mori, Yasuo, Shimoda, Kazuya, Ohshima, Kouichi, Mashiba, Koichi, Kikuchi, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410616/
https://www.ncbi.nlm.nih.gov/pubmed/37380472
http://dx.doi.org/10.3960/jslrt.22039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410616/
https://www.ncbi.nlm.nih.gov/pubmed/37380472
http://dx.doi.org/10.3960/jslrt.22039

Ejemplares similares